Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107382/0/en/Palvella-Therapeutics-Added-to-Russell-3000-and-Russell-2000-Indexes.html
23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103284/0/en/Palvella-Therapeutics-Completes-Enrollment-in-Phase-3-SELVA-Trial-of-QTORIN-Rapamycin-for-Microcystic-Lymphatic-Malformations-Exceeding-Enrollment-Target-by-Over-25.html
18 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/18/3101359/0/en/Palvella-Therapeutics-Granted-Sixth-U-S-Patent-Covering-0-1-20-Anhydrous-Compositions-of-Rapamycin-and-Other-mTOR-Inhibitors.html
09 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/09/3095755/0/en/Palvella-Therapeutics-Receives-Initial-Proceeds-from-FDA-Orphan-Products-Grant-to-Support-Phase-3-SELVA-Trial-of-QTORIN-Rapamycin-for-Microcystic-Lymphatic-Malformations.html
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088554/0/en/Palvella-Therapeutics-Strengthens-Executive-Leadership-Team-with-Appointment-of-Rare-Disease-Commercial-Veteran-Ashley-Kline-as-Chief-Commercial-Officer.html
15 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/15/3082041/0/en/Palvella-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
ABOUT THIS PAGE